---
category: news
title: "Deargen Signs Agreement With Sookmyung Women’s University Research & Business Development Foundation for Licensing ‘NASH Biomarker’ Technologies"
excerpt: "Deargen (President: Kilsoo Kang), an artificial intelligence (AI)-powered drug discovery and development company, announced on July 27 that it signed an agreement with Sookmyung Women’s University Research & Business Development Foundation for licensing biomarker technologies for determining the progression stage of NASH (non-alcoholic steatohepatitis) patients."
publishedDateTime: 2021-07-27T12:02:00Z
originalUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
webUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
type: article

provider:
  name: Cadillac Evening News
  domain: cadillacnews.com

topics:
  - AI in Healthcare
  - AI

secured: "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;Toc0S4lPVA4J960GFBTggA=="
---

